Baidu
map

广东发布55条医改新任务 4大亮点看过来

2017-07-10 佚名 医疗产业必粉

广东省人民政府网9日挂出了《广东省人民政府办公厅关于印发广东省深化医药卫生体制改革2017年重点工作任务的通知》(以下简称《通知》;全文附后),共提出了55项医改重点工作任务。

广东省人民政府网9日挂出了《广东省人民政府办公厅关于印发广东省深化医药卫生体制改革2017年重点工作任务的通知》(以下简称《通知》;全文附后),共提出了55项医改重点工作任务。

梳理发现,里面亮点纷呈:广东省将组建省医保基金管理中心,在全省所有公立医疗机构药品采购中实行“两票制”。同时,提升基层医疗服务能力、医联体建设、推进公立医院综合改革也一再被强调,还明确提出全省公立医院医疗费用平均增长幅度控制在10%以下。

亮点一:加强家庭医生签约服务

《通知》中推动落实的重点工作的第一条,就是要“加快推进家庭医生签约服务”,并明确从老年人、孕产妇、儿童、残疾人等人群以及慢性疾病和严重精神障碍患者等入手,2017年签约服务覆盖率达到30%,重点人群达到60%,把所有贫困人口纳入家庭医生签约服务范围。《通知》还指出,要制定分级诊疗常见病的入、出院标准和转诊指征、规范和流程,扩大基层首诊病种范围。

《通知》还指出,在有条件的城市推广深圳罗湖医院集团模式的紧密型医联体。所谓罗湖医院集团模式即以基层为重点、以健康为中心、以医保基金总额管理、结余奖励为核心的模式。这样一来,政府更多地把钱投进社康,做强居民身边的健康服务,让老百姓少生病、少住院、看好病、没负担,由保“医疗”到保“健康”。而在粤东西北地区以及惠州、江门、肇庆等15个地级市,《通知》明确提出将开展医联体试点工作。

为了进一步提升基层医疗服务能力,齐补“短板”,《通知》明确,45家中心卫生院升级建设要在2017年底前全部开工,同时,全面完成乡镇卫生院改造任务,推进社区卫生服务中心、村卫生站标准化建设。

此外,将新招收4200名住院医师和1080名全科(助理)医生参加规范化培训,农村卫生人才订单定向招生规模扩大到1000名,实施产科、儿科医生转岗培训项目,并为粤东西北地区基层医疗卫生机构增设全科医生特设岗位。

亮点二:药品加成全取消

《通知》指出,广东所有公立医院都要在7月前全部取消药品加成(中药饮片除外),同步实施医疗服务价格调整。同时,扩大县级公立医院综合改革示范范围,全省至少建设一个国家级示范县。

2017年深圳、珠海、惠州、东莞、中山、江门、肇庆7市公立医院药占比(不含中药饮片)总体降到30%左右,百元医疗收入(不含药品收入)中消耗的卫生材料降到20元以下。关于控费,《通知》指出,全省公立医院医疗费用平均增长幅度控制在10%以下,并适时公布各市主要监测指标排序情况。

要推进现代医院管理制度建设,至少选择3个市开展试点,初步建立决策、执行、监督相互协调、相互制衡、相互促进的管理体制和治理机制。

亮点三:组建省医保基金管理中心

《通知》明确提出要改革医保管理体制,组建省医保基金管理中心。鼓励有条件的地级以上市开展设立医保基金管理中心试点。在珠海、中山、东莞等3个市开展医保基金管理体制机制改革试点。同时,要落实城乡居民医保财政补助由每人每年420元提高到450元的政策,同步提高个人缴费标准。

《通知》指出,要推进按病种收费工作,2017年年底前所有城市实行按病种收费的病种不少于100个。

所谓按病种收费,就是医疗机构在提供医疗服务过程中,以病种为计价单位向患者收取费用,收费标准包含患者从诊疗入院到按病种规范治疗出院所发生的诊断、治疗、手术、麻醉、护理、床位、药品及医疗耗材等各项费用。通过这一方式,可进一步规范医疗行为,控制医疗费用的不合理上涨,减轻患者负担。

亮点四:实行“两票制”建立健全短缺药品监测体系

《通知》明确,2017年年底前,在全省所有公立医疗机构药品采购中实行“两票制”。“两票制”指药品从药厂卖到一级经销商开一次发票,经销商卖到医院再开一次发票,以“两票”替代目前常见的七票、八票,减少流通环节的层层盘剥。

对于短缺药品,《通知》明确要建立健全短缺药品监测预警和分级应对体系,加强短缺药品储备。支持建设小品种药品集中生产基地。还强调坚持集中带量采购原则,推进实施公立医院药品分类采购,培育集中采购主体,鼓励跨区域联合采购和专科医院联合采购。

《通知》指出,医保药品目录同时适用于基层医疗卫生机构。同时,选择部分地区开展建立医院总药师制度试点。落实处方点评等制度。指导地方对辅助性、营养性等高价药品列出具体清单,实施重点监控。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1997703, encodeId=92f0199e7031a, content=<a href='/topic/show?id=d8d85803457' target=_blank style='color:#2F92EE;'>#新任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58034, encryptionId=d8d85803457, topicName=新任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Wed Aug 23 21:16:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286758, encodeId=a54b1286e588b, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Tue Jul 11 23:16:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220764, encodeId=bce1220e6463, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 10 17:26:22 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220752, encodeId=737a220e52dc, content=是否利于老百姓, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Jul 10 16:47:21 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220739, encodeId=8834220e39c0, content=好文章 学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0iaeHUsbIzwsociaXY4eY8DryoMrt2gEdB9WBJl32NBRdY2JLRtDPibf3KoIM53fldicMJYbSUWVaXU/0, createdBy=e6fc75818, createdName=maymoon1983, createdTime=Mon Jul 10 14:36:01 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220725, encodeId=099f220e2593, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jul 10 13:28:34 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220707, encodeId=25d8220e0776, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Mon Jul 10 12:04:00 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1997703, encodeId=92f0199e7031a, content=<a href='/topic/show?id=d8d85803457' target=_blank style='color:#2F92EE;'>#新任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58034, encryptionId=d8d85803457, topicName=新任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Wed Aug 23 21:16:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286758, encodeId=a54b1286e588b, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Tue Jul 11 23:16:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220764, encodeId=bce1220e6463, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 10 17:26:22 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220752, encodeId=737a220e52dc, content=是否利于老百姓, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Jul 10 16:47:21 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220739, encodeId=8834220e39c0, content=好文章 学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0iaeHUsbIzwsociaXY4eY8DryoMrt2gEdB9WBJl32NBRdY2JLRtDPibf3KoIM53fldicMJYbSUWVaXU/0, createdBy=e6fc75818, createdName=maymoon1983, createdTime=Mon Jul 10 14:36:01 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220725, encodeId=099f220e2593, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jul 10 13:28:34 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220707, encodeId=25d8220e0776, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Mon Jul 10 12:04:00 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-11 tidiq
  3. [GetPortalCommentsPageByObjectIdResponse(id=1997703, encodeId=92f0199e7031a, content=<a href='/topic/show?id=d8d85803457' target=_blank style='color:#2F92EE;'>#新任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58034, encryptionId=d8d85803457, topicName=新任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Wed Aug 23 21:16:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286758, encodeId=a54b1286e588b, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Tue Jul 11 23:16:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220764, encodeId=bce1220e6463, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 10 17:26:22 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220752, encodeId=737a220e52dc, content=是否利于老百姓, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Jul 10 16:47:21 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220739, encodeId=8834220e39c0, content=好文章 学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0iaeHUsbIzwsociaXY4eY8DryoMrt2gEdB9WBJl32NBRdY2JLRtDPibf3KoIM53fldicMJYbSUWVaXU/0, createdBy=e6fc75818, createdName=maymoon1983, createdTime=Mon Jul 10 14:36:01 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220725, encodeId=099f220e2593, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jul 10 13:28:34 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220707, encodeId=25d8220e0776, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Mon Jul 10 12:04:00 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 三生有幸9135

    学习一下谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1997703, encodeId=92f0199e7031a, content=<a href='/topic/show?id=d8d85803457' target=_blank style='color:#2F92EE;'>#新任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58034, encryptionId=d8d85803457, topicName=新任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Wed Aug 23 21:16:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286758, encodeId=a54b1286e588b, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Tue Jul 11 23:16:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220764, encodeId=bce1220e6463, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 10 17:26:22 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220752, encodeId=737a220e52dc, content=是否利于老百姓, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Jul 10 16:47:21 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220739, encodeId=8834220e39c0, content=好文章 学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0iaeHUsbIzwsociaXY4eY8DryoMrt2gEdB9WBJl32NBRdY2JLRtDPibf3KoIM53fldicMJYbSUWVaXU/0, createdBy=e6fc75818, createdName=maymoon1983, createdTime=Mon Jul 10 14:36:01 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220725, encodeId=099f220e2593, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jul 10 13:28:34 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220707, encodeId=25d8220e0776, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Mon Jul 10 12:04:00 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 楠博One

    是否利于老百姓

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1997703, encodeId=92f0199e7031a, content=<a href='/topic/show?id=d8d85803457' target=_blank style='color:#2F92EE;'>#新任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58034, encryptionId=d8d85803457, topicName=新任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Wed Aug 23 21:16:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286758, encodeId=a54b1286e588b, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Tue Jul 11 23:16:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220764, encodeId=bce1220e6463, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 10 17:26:22 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220752, encodeId=737a220e52dc, content=是否利于老百姓, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Jul 10 16:47:21 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220739, encodeId=8834220e39c0, content=好文章 学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0iaeHUsbIzwsociaXY4eY8DryoMrt2gEdB9WBJl32NBRdY2JLRtDPibf3KoIM53fldicMJYbSUWVaXU/0, createdBy=e6fc75818, createdName=maymoon1983, createdTime=Mon Jul 10 14:36:01 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220725, encodeId=099f220e2593, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jul 10 13:28:34 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220707, encodeId=25d8220e0776, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Mon Jul 10 12:04:00 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 maymoon1983

    好文章 学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1997703, encodeId=92f0199e7031a, content=<a href='/topic/show?id=d8d85803457' target=_blank style='color:#2F92EE;'>#新任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58034, encryptionId=d8d85803457, topicName=新任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Wed Aug 23 21:16:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286758, encodeId=a54b1286e588b, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Tue Jul 11 23:16:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220764, encodeId=bce1220e6463, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 10 17:26:22 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220752, encodeId=737a220e52dc, content=是否利于老百姓, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Jul 10 16:47:21 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220739, encodeId=8834220e39c0, content=好文章 学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0iaeHUsbIzwsociaXY4eY8DryoMrt2gEdB9WBJl32NBRdY2JLRtDPibf3KoIM53fldicMJYbSUWVaXU/0, createdBy=e6fc75818, createdName=maymoon1983, createdTime=Mon Jul 10 14:36:01 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220725, encodeId=099f220e2593, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jul 10 13:28:34 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220707, encodeId=25d8220e0776, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Mon Jul 10 12:04:00 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 139****5926

    好好文章学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1997703, encodeId=92f0199e7031a, content=<a href='/topic/show?id=d8d85803457' target=_blank style='color:#2F92EE;'>#新任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58034, encryptionId=d8d85803457, topicName=新任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Wed Aug 23 21:16:00 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286758, encodeId=a54b1286e588b, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Tue Jul 11 23:16:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220764, encodeId=bce1220e6463, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 10 17:26:22 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220752, encodeId=737a220e52dc, content=是否利于老百姓, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Mon Jul 10 16:47:21 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220739, encodeId=8834220e39c0, content=好文章 学习了 , beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0iaeHUsbIzwsociaXY4eY8DryoMrt2gEdB9WBJl32NBRdY2JLRtDPibf3KoIM53fldicMJYbSUWVaXU/0, createdBy=e6fc75818, createdName=maymoon1983, createdTime=Mon Jul 10 14:36:01 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220725, encodeId=099f220e2593, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jul 10 13:28:34 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220707, encodeId=25d8220e0776, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Mon Jul 10 12:04:00 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 dhzzm

    学习了分享了

    0

相关资讯

三明市市长:国家层面对医药行业进行五大综合整治

当前我国医改已挺进深水区和攻坚期,一些地方的医改虽然取得一些成效,积累一些经验做法,但还有很多环节需要从国家层面建立完善相关政策制度,进而推动医改的全面深化和落实。

“医改标杆”三明2017新目标:将建十个县级“医共体”

三明市已经形成了一张从市级到县级的公立医疗服务网络。在服务网络内,按病种付费将进一步延伸到个人自付。同时,降低职工医保普通门诊目录内中药饮片的报销比例,由原来的100%降低到80%。

北京医改3月成绩单:医事服务费补零差率损失 尚有结余

2017年4月8日零时,酝酿已久的北京市医药分开综合改革正式实施。全市3600多家医疗机构参与医改。

广州将全面取消药品加成 启动公立医院综合改革

根据国家、广东省关于深化医药卫生体制改革、价格机制改革的决策部署,广州市统筹推进广州市行政区域内中央、省、军队、武警在穗公立医院以及广州市属、区属城市公立医院的综合改革工作,并于2017年7月15日全面取消药品加成、启动公立医院综合改革。届时,将全面启动广州地区公立医院医疗服务价格调整工作。

北京适时松绑跨科开药 加速分级诊疗格局成形

“本次,市卫计委明确表示将出台适当放开跨科开药的相关规定,就是向社会释放了以往控制过严的跨科开药有望进一步‘松绑’的信号,也表明了要对现行制度进行充分改革的决心。”业内专家表示。

中国社科院朱恒鹏:三甲医院改不动也不想改 另谋出路吧

医改这些年,从医药分开到分级诊疗,“应该怎样”的设计不少。可本应是改革重点的三甲医院,基本不会顺着设计的方向动上一动。这倒也不难理解:一面给它得天独厚的土壤,一面却寄希望于它主动割肉,岂非天真?

Baidu
map
Baidu
map
Baidu
map